Young People MenB Vaccinations
UK Government Rolls Out MenB Vaccine for Young People Ahead of University Year
Key Points
The vaccine being rolled out is Bexsero (a two-dose course at least 28 days apart), designed to protect against most MenB strains; experts said protection is thought to last at least six years.
In England, NHS England’s vaccination director Caroline Temmink said eligible people will be contacted not only through the NHS App but also by “text and email,” and that “all pharmacies will be eligible to deliver” with “vaccine stock… supplied centrally.”
The programme is framed as risk-reduction ahead of the seasonal pattern of invasive meningococcal disease, with UKHSA noting cases tend to peak in October to November each year.
Wales set out specific invite/eligibility steps: 17–18-year-olds will receive an invitation letter from their health board starting 6 July, while those aged 18–25 starting higher or residential further education will need to contact their health board after 20 July; Wales’ Chief Medical Officer Professor Isabel Oliver said the vaccine is “safe and effective.”
The UK government has launched a time-limited MenB vaccination programme for nearly one million young people, following the country's largest ever meningitis B outbreak. The Kent cluster infected at least 21 people and killed two students in a single month, prompting Health Secretary James Murray to call the rollout urgent, saying the outbreak indicates "a possible change to the way MenB affects people." The Guardian
The vaccine, Bexsero, will be given as two doses at least 28 days apart. It is free on the NHS and open to Year 13 school leavers and under-25s starting university or residential further education in autumn 2026, including international students. Experts say protection lasts at least six years. Mirror
A Kent Nightclub Sparked a National Emergency
The crisis began on March 11 at Club Chemistry, a nightclub in Canterbury, Kent. A superspreader event triggered a wave of infections. Within days, 18-year-old student Juliette Kenny and a second student died. Yahoo News reported that the Kent cluster was described by officials as the "fastest growing and largest ever seen in the UK."
By April, a second cluster had appeared in Weymouth, Dorset, with further cases in Berkshire. UKHSA epidemiologist Shamez Ladhani warned the clusters were "unusual" and that the UK may face "more meningococcal disease activity in the coming years." Sharing vapes, drinks, and close contact in student halls were identified as key drivers. Newsy Today
Why This Age Group Was Left Unprotected Until Now
The UK added Bexsero to the infant schedule in September 2015. But protection from those early doses fades before adolescence. That means the current cohort of 17- to 24-year-olds grew up without it. Before 2026, the only option was a private course costing over £200 — creating what analysts called a "vaccine inequality" that only wealthier students could afford.
Teenagers were previously offered only the MenACWY jab in Years 9 and 10. That vaccine gives no protection against the B strain, which caused 313 confirmed cases in England in 2024/25 — 83% of all invasive meningococcal disease that year. The fatality rate for MenB is around 10%. GOV.UK The Kent outbreak forced a policy reversal the JCVI had long resisted on cost grounds. Yahoo News
England Rolls Out Via Pharmacies, Wales Via Health Boards
In England, NHS England vaccination director Caroline Temmink confirmed that "all pharmacies will be eligible to deliver" the vaccine, with stock "supplied centrally." Eligible young people will be contacted by text, email, and through the NHS App. Bookings open in mid-July, with clinical delivery starting in late July. Both doses must be completed by August to ensure protection before the autumn term. The Guardian
Wales is running its own parallel rollout. From July 6, health boards began posting invitation letters to 17- and 18-year-olds. From July 20, those aged 18 to 25 starting university or residential further education can contact their health board to book. Wales' Chief Medical Officer Professor Isabel Oliver called the vaccine "safe and effective" and urged all eligible young people to come forward promptly. Meningitis Now
Campaigners Welcome the Move, But Questions Remain
Meningitis Now CEO Dr. Tom Nutt called the decision a "major step forward," crediting the charity's "No Plan B for MenB" campaign for pushing the policy change. The National Pharmacy Association also welcomed the rollout. NPA chief Henry Gregg said it would be a "huge relief to parents" and proof that pharmacies can mobilise quickly. Meningitis Now
However, some friction remains. Community pharmacy bodies said funding negotiations were still "ongoing" as of the June 11 announcement. Critics also noted the programme is "one-off" — those aged 26 to 30, also born before the 2015 infant schedule, remain unprotected. Public health analysts have called the government's response "reactive" rather than precautionary, arguing it took two deaths and national headlines to force action. Mirror
Sentiment
Mostly NegativePublishers
19
Articles
27
Reach
46
